Brian T. Powl is Chief Commercial Officer of Kura Oncology, Inc.. Currently has a direct ownership of 15,000 shares of KURA, which is worth approximately $250,799. The most recent transaction as insider was on Jan 02, 2024, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15K
0% 3M change
n/a 12M change
Total Value Held $250,799

Brian T. Powl Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2024
BUY
Grant, award, or other acquisition
-
15,000 Added 50.0%
15,000 Common Stock

Also insider at

FATE
FATE THERAPEUTICS INC Healthcare
BTP

Brian T. Powl

Chief Commercial Officer
San Diego, CA

Track Institutional and Insider Activities on KURA

Follow Kura Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KURA shares.

Notify only if

Insider Trading

Get notified when an Kura Oncology, Inc. insider buys or sells KURA shares.

Notify only if

News

Receive news related to Kura Oncology, Inc.

Track Activities on KURA